Web Results

en.wikipedia.org/wiki/Cutter_Laboratories

In the 1980s, numerous companies, including Bayer's Cutter Biologic division, produced unsafe blood products to treat hemophilia. The pharmaceutical product —produced from blood from donors across the US—was contaminated with the HIV virus at a time when HIV could not be screened out. These problems led to ...

www.gene.com/media/press-releases/4724/1984-09-11/cutter-to-receive-factor-viii-license-fr

Tuesday, Sep 11, 1984. Cutter To Receive Factor VIII License From Genentech. Emeryville, Calif. -- September 11, 1984 --. Cutter Biological, a division of Miles Laboratories, Inc., and Genentech, Inc. announced today that basic terms of an agreement have been reached to grant Cutter rights to the production and marketing ...

www.nytimes.com/2003/05/22/business/2-paths-of-bayer-drug-in-80-s-riskier-one-steered-overseas.html

May 22, 2003 ... The Bayer unit, Cutter Biological, introduced its safer medicine in late February 1984 as evidence mounted that the earlier version was infecting hemophiliacs with H.I.V. Yet for over a year, the company continued to sell the old medicine overseas, prompting a United States regulator to accuse Cutter of ...

www.cbsnews.com/news/bayer-admits-it-paid-millions-in-hiv-infection-cases-just-not-in-english

Jan 28, 2011 ... But you have to pick through the French and Italian news media to find out that Bayer is finally writing checks to people who got AIDS because, in the 1980s, the Cutter Biological unit of Bayer ignored federal law to recruit prisoners, intravenous drug users, and high-risk gay men as donors of the blood ...

www.cbsnews.com/news/bayer-sold-hiv-risky-meds

May 22, 2003 ... Bayer division Cutter Biological continued selling old stocks of the medicine for more than a year after it introduced a version in February 1984 that was heat- treated to kill HIV, according to documents obtained by the Times. The medicine, called Factor VIII concentrate, can stop or prevent potentially fatal ...

openjurist.org/971/f2d/375/john-doe-v-cutter-biological-inc

971 F.2d 375. 36 Fed. R. Evid. Serv. 187, Prod.Liab.Rep. (CCH) P 13,258. John DOE, Plaintiff-Appellant, v. CUTTER BIOLOGICAL, INC., A DIVISION OF MILES LABORATORIES, INC., Miles Laboratories, Inc., Travenol Laboratories, Inc., Armour Pharmaceutical Corporation, Alpha Therapeutic Corporation and United States ...

law.justia.com/cases/federal/district-courts/FSupp/852/909/1736223

Cutter Biological, Inc., 911 F.2d 374, 376 (9th Cir. 1990), and Doe v. Cutter Biological, Inc., 971 F.2d 375 (9th Cir. 1992), the issuance of an Order of Certification seemed unavoidable and entirely appropriate to this court. Nevertheless, on March 17, 1994, much to this court's dismay, an Order Declining to Accept Certification ...

www.bayer.com/en/1974-1988.aspx

Apr 6, 2016 ... In the U.S., the company acquired Cutter Laboratories Inc. in 1974 and Miles Laboratories Inc. in 1978. This allowed Bayer to gain an important position in the ... In 1980 Bayer Tower Biology was introduced in Leverkusen for biological wastewater treatment. The fruits of Bayer's environmental protection ...

www.theguardian.com/world/2003/may/23/aids.suzannegoldenberg

May 23, 2003 ... A division of the German pharmaceutical company Bayer knowingly sold blood- clotting agents infected with HIV to Asia and Latin America months after withdrawing them from Europe and the US, an American newspaper claimed yesterday. Cutter Biological continued to dump stocks of the factor VIII ...